Diluting postmortem muscle for analysis can determine which low drug concentrations enter a published comparison. In one six-matrix study, investigators first compared the muscle-homogenate measurement with the quantitation limit and only then corrected qualifying results for dilution. That sequence matters when fewer muscle findings are interpreted as evidence of absent exposure.
What material was studied?
Øiestad and colleagues included 109 benzodiazepine- or z-hypnotic-positive autopsies from a 183-case specimen project. Samples were collected from June 2013 through November 2016, generally within one week after death.
The study paired peripheral and cardiac blood with pericardial fluid, psoas muscle, lateral vastus muscle and vitreous humor. Peripheral blood was expressed from femoral vessels after iliac-vein transection and cessation of initial flow. Samples remained at 4°C after laboratory arrival, typically for one to two weeks before project analysis.
A tissue result and a homogenate result are different measurements
Muscle preparation used approximately 3.5 g of tissue with 14 mL water. The investigators corrected measured homogenate concentrations using the actual tissue weight and added water. Under the study’s calculation, the nominal preparation produces approximately fivefold dilution.
The final muscle results were reported per tissue mass, in mg/kg, while blood and fluid results were in mg/L. A number measured in diluted homogenate should not be compared directly with a blood concentration before the preparation and unit conversion are considered.
The authors explicitly stated that muscle-homogenate measurements were evaluated against the quantitation limit first. Only values exceeding that limit were corrected for dilution and included. Mathematical correction did not rescue an excluded low measurement into the reported dataset.
An illustrative threshold shows why sequence matters
The confirmation-method quantitation limit listed for diazepam was 0.0071 mg/L. With an exactly fivefold preparation, the corresponding numerical threshold after correction would be approximately 0.0355 mg/kg of original muscle. This is an illustration using the paper’s preparation convention, not a newly validated tissue limit or a universal threshold for every muscle sample.
Actual dilution depended on the weighed tissue. The calculation also did not establish a detection limit. A specimen that failed the quantitative inclusion rule was not thereby proof that no diazepam was present.
What did the authors observe?
The paper reported fewer findings in muscle and considered dilution during homogenization a possible explanation. Missing muscle values became more frequent as peripheral-blood concentrations decreased. That was an interpretation of casework patterns, not a controlled experiment measuring how many findings dilution alone removed.
For diazepam, Table II listed 38 peripheral-blood findings, 30 psoas findings and 27 lateral-vastus findings. Their reported concentration medians were 0.15 mg/L, 0.14 mg/kg and 0.17 mg/kg. These different positive subsets cannot be treated as three interchangeable population distributions.
Analytical validation and study selection both matter
Routine screening and separate confirmation used UHPLC–MS/MS procedures. Whole-blood calibrators were used for all matrices, with separate alternative-matrix performance checks. The study selected cases through peripheral-blood findings, so it did not measure muscle screening sensitivity in all possible exposed decedents.
Most bodies had no or slight putrefaction; only four had moderate putrefaction. The results do not establish the same performance in severe decomposition or burns.
For case review, preserve the muscle site, tissue weight, dilution, measured homogenate result, reporting rule and corrected units. Neither an omitted low result nor a corrected positive concentration independently establishes dose, impairment or cause of death. See also matrix-dependent clonazepam parent/metabolite relationships.
Primary source
Øiestad EL, Øiestad ÅML, Middelkoop G, Brochmann GW, Thaulow CH, Vindenes V. Comparative Study of Postmortem Concentrations of Benzodiazepines and Z-Hypnotics in Several Different Matrices. Journal of Analytical Toxicology. 2023;47:287–298. doi:10.1093/jat/bkac106.
Leave a Reply